Document:

Exhibit 10.9

 

US
ASIAN CONSULTING GROUP, LLC

32
Camlet Court

Roseland,
New Jersey 07068

 

Dated
as of March 30, 2022

 

Nexalin
Technologies, Inc.

1776
Yorktown, Suite 550

Houston,
Texas 77056

Attn.:
Mark White, CEO

 

Re:
Deferral of Consulting Fee

 

Ladies
and Gentlemen:

 

We
refer to the Consulting Agreement, as amended, dated as of May 9, 2018 (“Consulting Agreement”) between US Asian Consulting
Group, LLC (“US Asian”) and Nexalin Technology, Inc.

 

This
letter confirms our agreement that US Asian has agreed to defer payments of $250,000 otherwise due to it in connection with fees owed
to it under Consulting Agreement. We further confirm that the payments have been deferred until December 15, 2022.

 

	 	Sincerely,
	 	 	 
	 	US ASIAN CONSULTING GROUP, LLC
	 	 	 
	 	By:	/s/
    Leonard
    Osser 
	 	 	Leonard
    Osser, Managing Member/PrincipalExhibit
10.10

 

SUPPLEMENTARY
AGREEMENT NO. 2 FOR JOINT VENTURE AGREEMENT

 

This
SUPPLEMENTARY AGREEMENT NO. 2 FOR JOINT VENTURE AGREEMENT is entered into as of the 9th day of March, 2022 by and between
NEXALIN TECHNOLOGY, INC. (’‘Nexalin”) and WIDER COM LIMITED (“Wider”). Nexalin and Wider are sometimes individually
referred to as a ’‘Party” and collectively as the “Parties”.

 

WHEREAS,
the Parties have previously entered into a Joint Venture Agreement dated as of September 21, 2018, as supplemented by a Supplementary
Agreement dated as of May 22, 2019 (the “Original Agreement”); and

 

WHEREAS,
the Parties have determined it to be in their best interests to amend or modify certain covenants, terms, and conditions of the Original
Agreement, as described herein.

 

NOW
THEREFORE, in consideration of the covenants and agreements contained herein and for other good and valuable consideration, the Parties
agree to the following.

 

1. All
terms not otherwise defined herein shall have the meanings ascribed to such terms in the Original Agreement.

 

2.
The Parties have not established the JV as of the date hereof. The Parties acknowledge to each other that their ability to establish
the JV has been impacted by (i) legal and regulatory changes in the United States and the People’s Republic of China,
including changes related to investments in, or operations related to, entities with ownership of entities or operations or intended
operations in the People’s Republic of China and (ii) changing business plans or intended use and markets for the Nexalin
Products. The Parties re-confirm their mutual commitment and covenants to continue their reasonable commercial efforts to establish
the JV as intended by the Original Agreement.

 

3.
The Parties will use their reasonable commercial efforts to negotiate, execute and deliver further documentation, including without limitation,
one or more Services Agreements, Distribution Agreements and JV Documents related to the establishment, funding and management of the
JV and the intended treatments, product markets and uses for the Nexalin Products within the next 180 days from the date hereof.

 

4.
All references to December 21, 2018, including, without limitation, references contained in Sections 2.3 and 3.3 are hereby modified
and amended to read September 30, 2022.

 

5.
Each Party hereby waives any existing Events of Default under the Original Agreement that it may have or assert as of the date hereof.

 

6. This
Agreement may be executed in multiple counterparts and by facsimile and/or by e-mail, and all executed counterparts together shall constitute
the original instrument.

 

IN
WITNESS WHEREOF, the Parties have caused this executed to be duly authorized and executed as of the 9th day of March, 2022.

 

	WIDER COM LIMITED	 	NEXALIN TECHNOLOGY, INC.
	 	 	 
	By:	/s/ ZHU YUN	 	By:	/s/ Mark White
	Name:	ZHU YUN	 	Name:	Mark White
	Title:	Chief Executive Officer	 	Title:	Chief Executive OfficerExhibit 10.11

 

AMENDMENT NO 1 TO EMPLOYMENT AGREMENT

BETWEEN

DAVID OWENS MD

AND

NEXALIN TECHNOLOGY INC.

 

This Amendment No. 1 to Employment Agreement
is made as of March _, 2022 by and between David Owens M.D. (“Executive”) and Nexalin Technology Inc. (the
“Company”).

 

WHEREAS, Executive and the Company executed an
Employment Agreement dated as of February 15, 2021 (“Prior Agreement”); and

 

WHEREAS, Executive and the Company desire to clarify
and amend certain terms of the Prior Agreement.

 

NOW THEREFORE, in consideration of the mutual
promises and covenants contained herein, and for other good and valuable consideration, the parties hereby agree to the following.

 

1. All terms on otherwise defined herein shall
have the meaning ascribed to such terms in the Prior Agreement.

 

2. The parties agree that all amounts due and payable to Executive,
for services performed in 2021 and for any other amounts which may have been due and payable through 2021, has been paid on March 10,
2021 by the issuance of Common Stock.

 

3. For the 2022 employment year, Executive shall
not be entitled to compensation unless and until the Company completes its initial public offering under the Securities Act of 1933, as
amended. For purposes of determining the number of shares of Common Stock issuable to Executive, the value of such shares for the 2022
year shall equal the price of the Company’s Common Stock in its initial public offering. Further, assuming the Company has completed
its initial public offering the shares payable and issuable to Executive shall be deemed earned and issued on December 23, 2022.

 

4. Commencing with January 1, 2023, for each subsequent
year of services provided by Executive under the Prior Agreement, as amended by this Amendment, the shares payable and issuable to Executive
for each year of service shall be deemed earned and issuable on December 23rd of each calendar year.

 

5. All other terms and conditions of the Prior Agreement shall remain
in full force and effect.

 

IN WITNESS WHEREOF, the parties have executed
this Agreement on the date and year first above written.

 

	NEXALIN TECHNOLOGY INC.	 
	 	 
	By:	/s/ Mark White	 
	Name:	Mark White	 
	Title:	Chief Executive Officer	 
	 	 
	/s/ DAVID OWENS, MD	 
	DAVID OWENS, MDExhibit 10.14

 

PROMISSORY NOTE

 

	November 1, 2021	$200,000

 

For Value Received, NEXALIN TECHNOLOGY,
INC., a Nevada corporation (the “Maker”) promises to pay to the order of MARK WHITE (the “Payee”) the principal
sum of TWO HUNDRED THOUSAND DOLLARS ($200,000) (the “Loan”). The entire unpaid balance and interest thereon of the Loan as
set forth below shall be due and payable on the earlier to occur of (i) October 31, 2022 or (ii) the date of the consummation of the initial
public offering (the “IPO”) of the Maker (the “Maturity Date”), unless payment is accelerated as herein provided,
by reason of the occurrence of an “Event of Default” as set forth and defined below.

 

The Loan shall bear
interest at a rate equal to nine (9.0%) percent per annum, payable on the Maturity Date, when the entire unpaid balance and interest in
an amount equal to EIGHTEEN THOUSAND DOLLARS ($18,000) shall be due and payable. In no event shall interest exceed the maximum legal rate
permitted for the Maker. The Maker shall not make any payment hereunder from proceeds it receives from the IPO.

 

If any payment hereunder
is due on a day which is a holiday in the State of New York, such payment shall be made on the next succeeding business day. All payments
by the Maker on account of principal, interest or fees hereunder shall be made in lawful money of the United States of America, in immediately
available funds.

 

The Maker agrees that
if an attorney is retained to enforce or collect this Note or any other obligations by reason of non-payment of this Note when due or
made due hereunder, a reasonable attorneys’ fee shall be paid in addition, which fee shall be the reasonable value of the attorneys’
services.

 

This Note may be prepaid
in whole or in part at any time, without premium or penalty of any kind. All prepayments of this Note shall be applied first to accrued
and unpaid interest, and then to the outstanding principal amount.

 

The occurrence and continuance
of any one or more of the following events with respect to the Maker will constitute an event of default hereunder (each an “Event
of Default”): (i) any failure by the Maker to make a payment of principal or interest under this Note; (ii) the making of an assignment
for the benefit of the Maker’s creditors, unless such assignment is dismissed within ninety (90) days; (iii) the appointment of
a trustee, receiver or liquidator for the Maker or for any of its property, unless such appointment is dismissed within ninety (90) days;
(iv) the commencement of any proceedings by the Maker under any bankruptcy, reorganization, arrangement of debt, insolvency, readjustment
of debt, or receivership, law or statute, unless such proceedings are dismissed within ninety (90) days; or (v) the commencement of any
such proceedings without the consent of the Maker, unless such proceedings are dismissed within ninety (90) days.

 

Upon the occurrence of an Event of Default (unless such Event
of Default has been waived by the Payee), all sums owing under this Note, if not then due or payable, shall become due and payable immediately
without demand or notice and the Payee or holder hereof shall have the right to exercise any and all rights and remedies available to
it under applicable law, including, without limitation, the right to collect from the Maker all sums due under this Note.

 

     

     

    

 

This Note shall be
governed by the laws of the State of Delaware. The Payee and the Maker hereby irrevocably consent to the jurisdiction of any Delaware
State or Federal court located in Delaware over any action or proceeding arising out of any dispute between them. The Payee or any
holder may accept late payments, or partial payments, even though marked “payment in full” or containing words of similar
import or other conditions, without waiving any of its rights. No amendment, modification, or waiver of any provision of this Note nor
consent to any departure by the Maker therefrom shall be effective, irrespective of any course of dealing, unless the same shall be in
writing and signed by the Payee, and then such waiver or consent shall be effective only in the specific instance and for the specific
purpose for which given.

 

This Note shall be
binding upon the Maker and the Maker’s successors and assigns and shall inure to the benefit of and be enforceable by each person
who shall be the holder of this Note from time to time and each such person’s successors, assigns, heirs, executors and administrators.

 

The rights and remedies
of the Payee provided for hereunder are cumulative with the rights and remedies of the Payee available under any other instrument or agreement
or under applicable law.

 

	 	NEXALIN TECHNOLOGY, INC.
	 	 	 
	 	By:	/s/ Mark
    White
	 	Name:	Mark White
	 	Title:	CEO
	 	 	 
	 	Address:  	1776 Yorktown Street, Suite 550A 

Houston, TX 77056

 

    2

     

    

 

Mark White

c/o 1776 Yorktown, Suite 550

Houston, Texas 77056

 

Dated as of March 30, 2022

 

Nexalin Technologies, Inc.

1776 Yorktown, Suite 550

Houston, Texas 77056

Attn.: Mark White, CEO

 

		Re:	Deferral of Note Payment 

 

Ladies and Gentlemen:

 

Reference is made to that Promissory Note dated as of November 21,
2022 (“Note”) in favor of the undersigned in the principal amount of $200.000.

 

This letter shall constitute my agreement, as the Payee under the
Note, that the undersigned has agreed to defer payment of principal and interest otherwise due to me under the Note until December 15,
2022.

 

Therefore, the definition of Maturity Date as defined in the Note
shall be amended, and hereby is amended, in its entirety, to be December 15, 2022. All other terms of the Note shall remain in full force
and effect.

 

	 	/s/ Mark White
	 	Mark White

 

Accepted and Agreed:

 

As of March 30, 2022

 

NEXALIN TECHNOLOGY, INC.

 

	By:  	/s/ Marilyn Elson

Marilyn Elson

Chief Financial Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]